Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Health & Science
Recent news which mentions Health & Science
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
From pills to new uses, here's what Eli Lilly’s top scientist sees as the future of weight loss drugs
February 20, 2025
Tags
Biotech and Pharmaceuticals
Science
Health & Science
From
CNBC.com News
Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s
February 19, 2025
Tags
Science
Health & Science
Health care industry
From
CNBC.com News
UnitedHealthcare is offering buyouts to employees in benefits unit, could pursue layoffs, sources say
February 19, 2025
Tags
Pharmaceuticals
Labor economy
Health care industry
From
CNBC.com News
AI health-care startup OpenEvidence raises funding from Sequoia at $1 billion valuation
February 19, 2025
Tags
AI / Artificial Intelligence
Health & Science
Venture capital
From
CNBC.com News
Hims & Hers to offer at-home blood draws and lab testing with new acquisition
February 19, 2025
Tags
Technology
Hims & Hers Health Inc
Business
From
CNBC.com News
High-cost sickle cell gene therapies push insurers and Medicaid programs to find new payment models
February 18, 2025
Tags
Business News
Health insurance
CVS Health Corp
From
CNBC.com News
Innovaccer launches AI agents for doctors and hospitals to address burnout
February 17, 2025
Tags
Breaking News: Technology
Health care industry
Alphabet Inc
From
CNBC.com News
Moderna beats on revenue but loses more than expected as it scales down manufacturing
February 14, 2025
Tags
Business News
Biotech and Pharmaceuticals
Moderna Inc
From
CNBC.com News
CVS shares are up 45% this year — here's why it may be starting to turn its business around
February 13, 2025
Tags
Breaking News: Business
Companies
Biotechnology
From
CNBC.com News
Prenuvo adds new health tests to flagship full-body scan, raises $120 million in fresh funding
February 13, 2025
Tags
Health & Science
Business News
Health care industry
From
CNBC.com News
U.S. investors, Big Pharma race to find new medicines in China
February 13, 2025
Tags
Summit Therapeutics Inc
Health & Science
Health care industry
From
CNBC.com News
Healthy Returns: What to know about Trump's NIH funding cuts
February 12, 2025
Tags
Health & Science
Labor economy
Health care industry
From
CNBC.com News
CVS CEO defends pharmacy middlemen, accuses drugmakers of 'monopolistic' practices
February 12, 2025
Tags
Breaking News: Business
CVS Health Corp
Companies
From
CNBC.com News
Neuralink competitor Paradromics secures investment from Saudi Arabia's Neom
February 12, 2025
Tags
Breaking News: Technology
Health care industry
Health & Science
From
CNBC.com News
Apple launches first major health study in 5 years. Here's how you can opt in
February 12, 2025
Tags
Technology
Apple Inc
Internet
From
CNBC.com News
Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short
February 12, 2025
Tags
Health care industry
Biotech and Pharmaceuticals
Business News
From
CNBC.com News
CVS results top estimates even as high medical costs drag down insurance unit
February 12, 2025
Tags
Biotech and Pharmaceuticals
Health care industry
Business News
From
CNBC.com News
Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
February 10, 2025
Tags
Novo Nordisk A/S
Government and politics
Breaking News: Business
From
CNBC.com News
Hims & Hers faces scrutiny from lawmakers over 'misleading' Super Bowl ad
February 07, 2025
Tags
Novo Nordisk A/S
Technology
Hims & Hers Health Inc
From
CNBC.com News
Doximity shares pop 30% on revenue beat, rosy guidance
February 07, 2025
Tags
Technology
Doximity Inc
Social Media
From
CNBC.com News
Alphabet's Verily to sell Granular insurance business to Elevance Health
February 06, 2025
Tags
Elevance Health Inc
Internet
Health & Science
From
CNBC.com News
Doximity shares soar 21% after company beats on revenue, raises fiscal year guidance
February 06, 2025
Tags
Technology
Doximity Inc
Social Media
From
CNBC.com News
Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
February 06, 2025
Tags
Biotech and Pharmaceuticals
Health care industry
LILLY DRN
From
CNBC.com News
Eli Lilly posts mixed quarter even as demand for weight loss, diabetes drugs soars
February 06, 2025
Tags
Health care industry
Biotech and Pharmaceuticals
Business News
From
CNBC.com News
Bristol Myers Squibb plans $2 billion in cost cuts by 2027, issues weak guidance
February 06, 2025
Tags
Business News
Bristol/Myers Squibb Co
Health care industry
From
CNBC.com News
Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs
February 05, 2025
Tags
Biotech and Pharmaceuticals
Health care industry
Health & Science
From
CNBC.com News
Teladoc Health to acquire Catapult Health in $65 million deal
February 05, 2025
Tags
Technology
Teladoc Health Inc
Internet
From
CNBC.com News
Healthy Returns: Why people quit weight loss, diabetes drugs within one year
February 04, 2025
Tags
LILLY DRN
Novo Nordisk A/S
Social issues
From
CNBC.com News
Vaccine stocks fall as Senate panel advances RFK Jr.'s nomination for HHS secretary
February 04, 2025
Tags
Business News
Health care industry
Novavax Inc
From
CNBC.com News
Pfizer tops earnings estimates as Covid product sales beat expectations and cost cuts pay off
February 04, 2025
Tags
Business News
Health care industry
Biotech and Pharmaceuticals
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.